We read with great interest the article by Porth et al. [1], titled "Gaps in Glycaemic Monitoring and Underuse of Cardioprotective Glucose-lowering Agents: Challenges of inpatient diabetes care identified by EFIM’s Diabesity Day Survey 2024." The authors provide a valuable snapshot of current inpatient diabetes management practices across Europe, highlighting significant gaps in guideline adherence. While the study successfully identifies key areas for quality improvement, several methodological limitations warrant careful consideration to fully appreciate the clinical applicability of its findings.
